2269:TSEMeiji Holdings Co., Ltd. Analysis

The moving-average structure behind OliX Pharmaceuticals, Inc is bearish at KRW 96,400.00, with short-term averages lagging the long-term ones. It has lost 12.0% over the past 30 days. With RSI at 41.9 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at KRW 91,200.00 up to resistance at KRW 141,400.00.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 58.0%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 107.0%, a beta of 1.19 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.